Legend Biotech Corp (LEGN) stock
LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 10, 2026Score 3/30
$16.25+0.14 (+0.87%)
Close on Nov 18, 2026Market cap $3.01BP/E –Yield –
Legend Biotech price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Legend Biotech's price to sales ratio was 2.9× on Nov 11, 2026, against 5.6× a year earlier. Over the last 5 years it ranged from 2.9× to 112.6×, with a median of 27.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.9× | −1.5 |
| 2025 | Dec 31, 2025 | 4.4× | −7.0 |
| 2024 | Dec 31, 2024 | 11.4× | −32.9 |
| 2023 | Dec 29, 2023 | 44.3× | −57.8 |
| 2022 | Dec 30, 2022 | 102.2× | +28.7 |
| 2021 | Dec 31, 2021 | 73.4× | +26.5 |
| 2020 | Dec 31, 2020 | 46.9× | – |
See a number that looks wrong?